Results 81 to 90 of about 1,763 (188)
Clear Cell Renal Cell Carcinoma: Rare and Atypical Metastatic Localizations—A Case Series
Introduction Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of kidney cancer, characterized by its high degree of vascularity and metastatic potential. Although common metastatic sites include the lungs, lymph nodes, bones, liver, adrenal glands, and brain, rare localizations, such as those observed in the pancreas, gallbladder ...
Roosvelt Tessa Djambong +7 more
wiley +1 more source
Introduction The progression patterns, dispositions, and outcomes of patients with advanced hepatocellular carcinoma (HCC) who achieved durable responses with immunotherapy remain poorly characterized.
Su Y.-Y. (17887331) +19 more
core +1 more source
Sarcomatoid carcinoma is a heterogeneous and rare subset of non–small cell lung cancers (NSCLCs), comprising pleomorphic carcinoma, spindle cell carcinoma, giant cell carcinoma, pulmonary blastoma, and carcinosarcoma. Pulmonary spindle cell carcinoma accounts for less than 1% of all NSCLC cases.
Raheel Siddiqui +3 more
wiley +1 more source
International audienceContext : Nonsmall Cell Lung Cancer (NSCLC) treatment relies on first-line immunotherapy as single agent or combined with chemotherapy. Oligoprogression may be observed in this setting.
Basse, C. +13 more
core +1 more source
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis [PDF]
Locoregional treatment with radical intent should be considered during therapy with targeted agents in patients with metastatic renal cell carcinoma (mRCC) in order to achieve a complete response, especially in the setting of an oligo-progression in one ...
Maruzzo M +62 more
core +1 more source
NSCLC With Synchronous EGFR Mutations in Li Fraumeni Syndrome: A Case Report
We report a case of a patient with Li Fraumeni Syndrome (LFS) who developed synchronous EGFR exon deletion 19 and EGFR exon 20 insertion NSCLC and characterize the diagnostic and therapeutic challenges in managing her care.
Stephen V. Liu, MD +1 more
core +1 more source
Introduction: Therapy options for patients with oligoprogressive malignant pleural mesothelioma (MPM) are limited. Stereotactic Body Radiotherapy (SBRT) may be a promising therapeutic option, as it delivers a localized ablative dose of radiation and ...
Christina Schröder +7 more
doaj +1 more source
Radiotherapy in Oligometastatic and Oligoprogressive Disease
Mihriban Erdoğan +7 more
openaire +1 more source
Consolidative radiotherapy in oligometastatic and oligoprogressive NSCLC: A systematic review
Consolidative radiation is increasingly regarded as an effective treatment for oligometastatic and oligoprogressive non-small cell lung cancer (NSCLC). This systematic review examines the clinical evidence on the significance of consolidative radiation in improving outcomes in NSCLC, including progression-free survival and overall survival. Innovations
Nazmul Hasan +3 more
openaire +2 more sources
Recently, the development of targeted therapy approaches such as those based on tyrosine kinase inhibitor (TKI) greatly improved the clinical outcomes of patients affected by oncogene addicted advanced non-small cell lung cancer (NSCLC).
Francesca Di Pressa +5 more
doaj +1 more source

